Structural determinants of growth factor binding and specificity by VEGF receptor 2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 6, 2010, Pages 2425-2430

  Leppänen, Veli Matti ^a   Prota, Andrea E ^b   Jeltsch, Michael ^a   Anisimov, Andrey ^a   Kalkkinen, Nisse ^c   Strandin, Tomas ^d   Lankinen, Hilkka ^d   Goldman, Adrian ^c   Ballmer Hofer, Kurt ^b   Alitalo, Kari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Lymphangiogenesis; Vascular endothelial growth factor C; Vascular endothelial growth factor receptor 2

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ANIMALS; BINDING SITES; CELL LINE; CELL SURVIVAL; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; KINETICS; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SPODOPTERA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 77249148863     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914318107     Document Type: Article

References (45)

1. Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol, 21:154-165.
2. Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res, 312:549-560.
3. Mäkinen T, et al. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J, 20:4762-4773.
4. Kärkkäinen MJ, et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol, 5:74-80.
5. Benest AV, Harper SJ, Ylä-Herttuala SY, Alitalo K, Bates DO (2008) VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovasc Res, 78:315-323.
6. Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K (2008) Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am J Pathol, 173:1891-1901.
7. Anisimov A, et al. (2009) Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res, 104:1302-1312.
8. Tammela T, et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature, 454:656-660.
9. Dixelius J, et al. (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem, 278:40973-40979.
10. Kärpänen T, et al. (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J, 20:1462-1472.
11. Cebe-Suarez S, et al. (2006) A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell Mol Life Sci, 63:2067-2077.
12. Cebe-Suarez S, Zehnder-Fjallman A, Ballmer-Hofer K (2006) The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci, 63:601-615.
13. Kawamura H, et al. (2008) Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood, 112:3638-3649.
14. Cebe-Suarez S, et al. (2008) Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J, 22:3078-3086.
15. Robinson CJ, Stringer SE (2001) The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci, 114:853-865.
16. Vitt UA, Hsu SY, Hsueh AJ (2001) Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol, 15:681-694.
17. Oefner C, D'Arcy A, Winkler FK, Eggimann B, Hosang M (1992) Crystal structure of human platelet-derived growth factor BB. EMBO J, 11:3921-3926.
18. Reigstad LJ, et al. (2003) Platelet-derived growth factor (PDGF)-C, a PDGF family member with a vascular endothelial growth factor-like structure. J Biol Chem, 278:17114-17120.
19. Muller YA, Heiring C, Misselwitz R, Welfle K, Welfle H (2002) The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor. J Biol Chem, 277:43410-43416.
20. Joukov V, et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 15:290-298.
21. Jeltsch M, et al. (2006) Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns. J Biol Chem, 281:12187-12195.
22. Joukov V, et al. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J, 16:3898-3911.
23. Lyttle DJ, Fraser KM, Fleming SB, Mercer AA, Robinson AJ (1994) Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol, 68:84-92.
24. Wise LM, et al. (2003) Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J Biol Chem, 278:38004-38014.
25. Mercer AA, et al. (2002) Vascular endothelial growth factors encoded by Orf virus show surprising sequence variation but have a conserved, functionally relevant structure. J Gen Virol, 83:2845-2855.
26. Muller YA, et al. (1997) Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA, 94:7192-7197.
27. Iyer S, et al. (2001) The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem, 276:12153-12161.
28. Iyer S, Scotney PD, Nash AD, Ravi Acharya K (2006) Crystal structure of human vascular endothelial growth factor-B: Identification of amino acids important for receptor binding. J Mol Biol, 359:76-85.
29. Pieren M, et al. (2006) Crystal structure of the Orf virus NZ2 variant of vascular endothelial growth factor-E. Implications for receptor specificity. J Biol Chem, 281:19578-19587.
30. Wiesmann C, et al. (1997) Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell, 91:695-704.
31. Christinger HW, Fuh G, de Vos AM, Wiesmann C (2004) The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. J Biol Chem, 279:10382-10388.
32. Davis-Smyth T, Presta LG, Ferrara N (1998) Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability. J Biol Chem, 273:3216-3222.
33. Fuh G, Li B, Crowley C, Cunningham B, Wells JA (1998) Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem, 273:11197-11204.
34. Ruch C, Skiniotis G, Steinmetz MO, Walz T, Ballmer-Hofer K (2007) Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Nat Struct Mol Biol, 14:249-250.
35. Harpaz Y, Chothia C (1994) Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol, 238:528-539.
36. Yuzawa S, et al. (2007) Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell, 130:323-334.
37. Chen X, Liu H, Focia PJ, Shim AH, He X (2008) Structure of macrophage colony stimulating factor bound to FMS: Diverse signaling assemblies of class III receptor tyrosine kinases. Proc Natl Acad Sci USA, 105:18267-18272.
38. Joukov V, et al. (1998) A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem, 273:6599-6602.
39. Baldwin ME, et al. (2001) The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem, 276:19166-19171.
40. Toivanen PI, et al. (2009) Novel vascular endothelial growth factor D variants with increased biological activity. J Biol Chem, 284:16037-16048.
41. Kiba A, Yabana N, Shibuya M (2003) A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling. J Biol Chem, 278:13453-13461.
42. Dell'Era Dosch D, Ballmer-Hofer K (2010) Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers. FASEB J, 24:32-38.
43. Yang Y, Yuzawa S, Schlessinger J (2008) Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization. Proc Natl Acad Sci USA, 105:7681-7686.
44. Skiniotis G, Lupardus PJ, Martick M, Walz T, Garcia KC (2008) Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol Cell, 31:737-748.
45. Alitalo K, Adams RH (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol, 8:464-478.